{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"2.02","upperLimit":"4.66","value":"3.7"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"82"}],"units":"Participants"}],"description":"To evaluate progression-free survival","dispersionType":"95% Confidence Interval","groups":[{"description":"Open-label ATG-010 80mg plus Dexamethasone 20 mg\n\nATG-010: ATG-010 (Selinexor) will be given at an oral fixed milligram (mg) dose of 80 mg twice weekly each week for four-week cycles (total of 8 ATG-010 doses per cycle).\n\nDexamethasone 20 mg will be given with each dose of ATG-010 (Selinexor)","id":"OG000","title":"ATG-010 + Dexamethasone"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"12 months","title":"Progression-Free Survival (PFS)","type":"SECONDARY","unitOfMeasure":"month"}